202 related articles for article (PubMed ID: 32415873)
1. Identification of an ATP metabolism-related signature associated with prognosis and immune microenvironment in gliomas.
Huang R; Li G; Wang Z; Hu H; Zeng F; Zhang K; Wang K; Wu F
Cancer Sci; 2020 Jul; 111(7):2325-2335. PubMed ID: 32415873
[TBL] [Abstract][Full Text] [Related]
2. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
Zhang C; Li J; Wang H; Song SW
Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
[TBL] [Abstract][Full Text] [Related]
3. The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning.
Zhang N; Dai Z; Wu W; Wang Z; Cao H; Zhang Y; Wang Z; Zhang H; Cheng Q
Front Immunol; 2021; 12():656541. PubMed ID: 33959130
[TBL] [Abstract][Full Text] [Related]
4. Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics.
Lin WW; Ou GY; Zhao WJ
J Cell Mol Med; 2021 Nov; 25(21):10111-10125. PubMed ID: 34597473
[TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Qi Y; Chen D; Lu Q; Yao Y; Ji C
Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
[TBL] [Abstract][Full Text] [Related]
7. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
8. TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas.
Chen R; Wang X; Dai Z; Wang Z; Wu W; Hu Z; Zhang X; Liu Z; Zhang H; Cheng Q
Front Immunol; 2021; 12():713757. PubMed ID: 34712225
[TBL] [Abstract][Full Text] [Related]
9. Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma.
Zhou Z; Huang R; Chai R; Zhou X; Hu Z; Wang W; Chen B; Deng L; Liu Y; Wu F
Aging (Albany NY); 2018 Nov; 10(11):3185-3209. PubMed ID: 30407923
[TBL] [Abstract][Full Text] [Related]
10. Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas.
Bockmayr M; Klauschen F; Maire CL; Rutkowski S; Westphal M; Lamszus K; Schüller U; Mohme M
Cancer Immunol Res; 2019 Sep; 7(9):1401-1411. PubMed ID: 31266783
[TBL] [Abstract][Full Text] [Related]
11. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
12.
Hu Z; Qu S
Front Immunol; 2021; 12():683572. PubMed ID: 34267752
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance.
Wang QW; Lin WW; Zhu YJ
Cell Commun Signal; 2022 Jan; 20(1):6. PubMed ID: 35000592
[TBL] [Abstract][Full Text] [Related]
14. An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment.
Abou Khouzam R; Rao SP; Venkatesh GH; Zeinelabdin NA; Buart S; Meylan M; Nimmakayalu M; Terry S; Chouaib S
Front Immunol; 2021; 12():680435. PubMed ID: 34093582
[TBL] [Abstract][Full Text] [Related]
15. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
[TBL] [Abstract][Full Text] [Related]
17. Tumor Purity as an Underlying Key Factor in Glioma.
Zhang C; Cheng W; Ren X; Wang Z; Liu X; Li G; Han S; Jiang T; Wu A
Clin Cancer Res; 2017 Oct; 23(20):6279-6291. PubMed ID: 28754819
[No Abstract] [Full Text] [Related]
18. Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival.
Wang QW; Bao ZS; Jiang T; Zhu YJ
Cancer Immunol Immunother; 2022 Apr; 71(4):953-966. PubMed ID: 34535804
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas.
Huang R; Li G; Wang K; Wang Z; Zeng F; Hu H; Jiang T
Front Cell Dev Biol; 2021; 9():619396. PubMed ID: 34307339
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas.
Liu X; Li Y; Sun Z; Li S; Wang K; Fan X; Liu Y; Wang L; Wang Y; Jiang T
Cancer Med; 2018 Sep; 7(9):4273-4283. PubMed ID: 30117304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]